Kartik Krishnan
Chief Medical Officer · Pasithea Therapeutics Corp.
Individual
- 2026
- May 5, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kartik Krishnan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Lawrence Steinman - $100K in KTTA purchases and sales in the last 12 months
- Coastlands Capital LP - $53K in KTTA purchases and sales in the last 12 months
- Tiago Marques - $25K in KTTA purchases and sales in the last 12 months
- Simon Dumesnil - $25K in KTTA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kartik Krishnan?
Kartik Krishnan is a corporate insider, tracked as Chief Medical Officer of Pasithea Therapeutics Corp. (KTTA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Kartik Krishnan last file a Form 4?
The only primary Form 4 on record is dated 5 May 2026.